SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Samsung Biologics Signs $324.8 Million Drug Manufacturing Contract

Samsung Biologics signed a drug manufacturing contract worth USD 324.8 million.

DXY
SquawkNews Desk 1 updates Updated Nov 02, 2026, 11:37 PM UTC

Story updates

11:37:39 PM UTC
SquawkNews
삼성바이오로직스, 글로벌 제약사와 324.8백만 달러 규모 의약품 위탁생산 계약 체결 Samsung Biologics가 2026년 11월 2일 글로벌 제약사와 KRW 434

Related stories

Anthropic Reports Third-Quarter Revenue; Losses Persist M impact | EQUITY | Nov 03, 2026, 12:33 AM UTC Disney Plans Thousands of Layoffs, Bloomberg News Reports Bloomberg News reports that Disney plans thousands of layoffs as executives seek to reduce costs. M impact | EQUITY | Nov 03, 2026, 12:32 AM UTC Disney reportedly considers cutting thousands of jobs Bloomberg News reported, citing people familiar with the matter, that Walt Disney is considering cutting thousands of jobs. L impact | EQUITY | Nov 03, 2026, 12:32 AM UTC Australian energy stocks drop over 4% Australian energy stocks fell more than 4%, tracking lower oil prices. M impact | EQUITY | Nov 03, 2026, 12:30 AM UTC Global market picture: S&P 500 -0.33%, Nasdaq 100 -1.08%; EUR/USD +0.07%, WTI -7.56% Global market picture. US index futures: S and P futures is down 0.33 percent, Nasdaq futures is down 1.08 percent, Dow futures is up 0.5 percent and Russell futures is up 0.07 per M impact | EQUITY | Nov 03, 2026, 12:30 AM UTC Samsung Biologics Signs Contract With Global Pharma Company Samsung Biologics signed a contract to manufacture products for a global pharmaceutical company. M impact | EQUITY | Nov 03, 2026, 12:27 AM UTC